nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2D6—epilepsy syndrome	0.113	0.583	CbGaD
Dapagliflozin—ABCB1—epilepsy syndrome	0.0804	0.417	CbGaD
Dapagliflozin—UGT2B7—Carbamazepine—epilepsy syndrome	0.0448	0.0871	CbGbCtD
Dapagliflozin—UGT1A9—Propofol—epilepsy syndrome	0.0396	0.077	CbGbCtD
Dapagliflozin—UGT1A9—Valproic Acid—epilepsy syndrome	0.0283	0.055	CbGbCtD
Dapagliflozin—UGT2B7—Valproic Acid—epilepsy syndrome	0.0268	0.052	CbGbCtD
Dapagliflozin—CYP2A6—Amobarbital—epilepsy syndrome	0.0258	0.0502	CbGbCtD
Dapagliflozin—CYP2A6—Propofol—epilepsy syndrome	0.0193	0.0374	CbGbCtD
Dapagliflozin—CYP2A6—Phenobarbital—epilepsy syndrome	0.0184	0.0358	CbGbCtD
Dapagliflozin—CYP1A1—Propofol—epilepsy syndrome	0.0164	0.032	CbGbCtD
Dapagliflozin—CYP1A1—Phenobarbital—epilepsy syndrome	0.0157	0.0305	CbGbCtD
Dapagliflozin—CYP2A6—Valproic Acid—epilepsy syndrome	0.0137	0.0267	CbGbCtD
Dapagliflozin—ABCB1—Levetiracetam—epilepsy syndrome	0.0134	0.026	CbGbCtD
Dapagliflozin—CYP2C9—Trimethadione—epilepsy syndrome	0.0117	0.0228	CbGbCtD
Dapagliflozin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.011	0.0214	CbGbCtD
Dapagliflozin—ABCB1—Clobazam—epilepsy syndrome	0.00927	0.018	CbGbCtD
Dapagliflozin—ABCB1—Lamotrigine—epilepsy syndrome	0.00892	0.0173	CbGbCtD
Dapagliflozin—CYP1A2—Carbamazepine—epilepsy syndrome	0.00878	0.0171	CbGbCtD
Dapagliflozin—CYP1A2—Primidone—epilepsy syndrome	0.0082	0.0159	CbGbCtD
Dapagliflozin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00792	0.0154	CbGbCtD
Dapagliflozin—ABCB1—Carbamazepine—epilepsy syndrome	0.00768	0.0149	CbGbCtD
Dapagliflozin—CYP2C9—Primidone—epilepsy syndrome	0.00739	0.0144	CbGbCtD
Dapagliflozin—CYP1A2—Propofol—epilepsy syndrome	0.00735	0.0143	CbGbCtD
Dapagliflozin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00733	0.0142	CbGbCtD
Dapagliflozin—CYP2C9—Phenytoin—epilepsy syndrome	0.0071	0.0138	CbGbCtD
Dapagliflozin—CYP1A2—Phenobarbital—epilepsy syndrome	0.00702	0.0136	CbGbCtD
Dapagliflozin—ABCB1—Phenytoin—epilepsy syndrome	0.00689	0.0134	CbGbCtD
Dapagliflozin—CYP3A4—Trimethadione—epilepsy syndrome	0.00681	0.0132	CbGbCtD
Dapagliflozin—CYP3A4—Felbamate—epilepsy syndrome	0.00681	0.0132	CbGbCtD
Dapagliflozin—CYP1A2—Diazepam—epilepsy syndrome	0.00666	0.0129	CbGbCtD
Dapagliflozin—CYP2C9—Propofol—epilepsy syndrome	0.00662	0.0129	CbGbCtD
Dapagliflozin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00641	0.0124	CbGbCtD
Dapagliflozin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00633	0.0123	CbGbCtD
Dapagliflozin—ABCB1—Phenobarbital—epilepsy syndrome	0.00614	0.0119	CbGbCtD
Dapagliflozin—ABCB1—Midazolam—epilepsy syndrome	0.00606	0.0118	CbGbCtD
Dapagliflozin—CYP2D6—Propofol—epilepsy syndrome	0.00605	0.0118	CbGbCtD
Dapagliflozin—CYP2C9—Diazepam—epilepsy syndrome	0.006	0.0117	CbGbCtD
Dapagliflozin—ABCB1—Diazepam—epilepsy syndrome	0.00582	0.0113	CbGbCtD
Dapagliflozin—CYP3A4—Clonazepam—epilepsy syndrome	0.00579	0.0113	CbGbCtD
Dapagliflozin—CYP3A4—Clobazam—epilepsy syndrome	0.00555	0.0108	CbGbCtD
Dapagliflozin—CYP1A2—Valproic Acid—epilepsy syndrome	0.00525	0.0102	CbGbCtD
Dapagliflozin—CYP2C9—Valproic Acid—epilepsy syndrome	0.00473	0.00919	CbGbCtD
Dapagliflozin—CYP3A4—Rufinamide—epilepsy syndrome	0.00472	0.00918	CbGbCtD
Dapagliflozin—CYP3A4—Carbamazepine—epilepsy syndrome	0.0046	0.00894	CbGbCtD
Dapagliflozin—CYP3A4—Primidone—epilepsy syndrome	0.0043	0.00835	CbGbCtD
Dapagliflozin—CYP3A4—Phenytoin—epilepsy syndrome	0.00413	0.00802	CbGbCtD
Dapagliflozin—CYP3A4—Propofol—epilepsy syndrome	0.00385	0.00748	CbGbCtD
Dapagliflozin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00368	0.00715	CbGbCtD
Dapagliflozin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00368	0.00715	CbGbCtD
Dapagliflozin—CYP3A4—Midazolam—epilepsy syndrome	0.00363	0.00705	CbGbCtD
Dapagliflozin—CYP3A4—Diazepam—epilepsy syndrome	0.00349	0.00678	CbGbCtD
Dapagliflozin—CYP3A4—Zonisamide—epilepsy syndrome	0.0034	0.00662	CbGbCtD
Dapagliflozin—SLC5A11—forebrain—epilepsy syndrome	0.00289	0.0966	CbGeAlD
Dapagliflozin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00275	0.00534	CbGbCtD
Dapagliflozin—SLC5A11—telencephalon—epilepsy syndrome	0.00266	0.0888	CbGeAlD
Dapagliflozin—CYP3A4—Topiramate—epilepsy syndrome	0.00248	0.00482	CbGbCtD
Dapagliflozin—SLC5A11—medulla oblongata—epilepsy syndrome	0.00209	0.0698	CbGeAlD
Dapagliflozin—SLC5A11—midbrain—epilepsy syndrome	0.00191	0.0638	CbGeAlD
Dapagliflozin—SLC5A11—spinal cord—epilepsy syndrome	0.00186	0.0622	CbGeAlD
Dapagliflozin—SLC5A4—head—epilepsy syndrome	0.00182	0.0609	CbGeAlD
Dapagliflozin—SLC5A4—nervous system—epilepsy syndrome	0.00173	0.0577	CbGeAlD
Dapagliflozin—Canagliflozin—ABCC2—epilepsy syndrome	0.00168	0.57	CrCbGaD
Dapagliflozin—SLC5A4—central nervous system—epilepsy syndrome	0.00166	0.0556	CbGeAlD
Dapagliflozin—SLC5A11—head—epilepsy syndrome	0.00166	0.0553	CbGeAlD
Dapagliflozin—SLC5A11—nervous system—epilepsy syndrome	0.00157	0.0524	CbGeAlD
Dapagliflozin—SLC5A11—central nervous system—epilepsy syndrome	0.00151	0.0505	CbGeAlD
Dapagliflozin—SLC5A11—cerebellum—epilepsy syndrome	0.00148	0.0493	CbGeAlD
Dapagliflozin—SLC5A4—brain—epilepsy syndrome	0.00132	0.0441	CbGeAlD
Dapagliflozin—SLC5A11—brain—epilepsy syndrome	0.0012	0.0401	CbGeAlD
Dapagliflozin—Canagliflozin—ALB—epilepsy syndrome	0.000647	0.22	CrCbGaD
Dapagliflozin—Canagliflozin—ABCB1—epilepsy syndrome	0.000617	0.21	CrCbGaD
Dapagliflozin—CYP2D6—hindbrain—epilepsy syndrome	0.00045	0.015	CbGeAlD
Dapagliflozin—CYP2A6—cerebellum—epilepsy syndrome	0.00034	0.0113	CbGeAlD
Dapagliflozin—CYP2A6—brain—epilepsy syndrome	0.000276	0.00921	CbGeAlD
Dapagliflozin—CYP2D6—brainstem—epilepsy syndrome	0.000258	0.00861	CbGeAlD
Dapagliflozin—CYP2D6—forebrain—epilepsy syndrome	0.000249	0.00831	CbGeAlD
Dapagliflozin—CYP2D6—telencephalon—epilepsy syndrome	0.000229	0.00764	CbGeAlD
Dapagliflozin—CYP1A1—head—epilepsy syndrome	0.000197	0.00659	CbGeAlD
Dapagliflozin—CYP1A1—nervous system—epilepsy syndrome	0.000187	0.00625	CbGeAlD
Dapagliflozin—CYP1A1—central nervous system—epilepsy syndrome	0.00018	0.00601	CbGeAlD
Dapagliflozin—ABCB1—forebrain—epilepsy syndrome	0.000179	0.00598	CbGeAlD
Dapagliflozin—ABCB1—telencephalon—epilepsy syndrome	0.000165	0.0055	CbGeAlD
Dapagliflozin—CYP1A1—brain—epilepsy syndrome	0.000143	0.00477	CbGeAlD
Dapagliflozin—CYP2D6—head—epilepsy syndrome	0.000142	0.00476	CbGeAlD
Dapagliflozin—CYP3A4—nervous system—epilepsy syndrome	0.000137	0.00458	CbGeAlD
Dapagliflozin—CYP2D6—nervous system—epilepsy syndrome	0.000135	0.00451	CbGeAlD
Dapagliflozin—CYP3A4—central nervous system—epilepsy syndrome	0.000132	0.00441	CbGeAlD
Dapagliflozin—CYP2D6—central nervous system—epilepsy syndrome	0.00013	0.00434	CbGeAlD
Dapagliflozin—ABCB1—medulla oblongata—epilepsy syndrome	0.000129	0.00432	CbGeAlD
Dapagliflozin—CYP2D6—cerebellum—epilepsy syndrome	0.000127	0.00424	CbGeAlD
Dapagliflozin—Rash—Lacosamide—epilepsy syndrome	0.000125	0.000835	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000125	0.000835	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000125	0.000835	CcSEcCtD
Dapagliflozin—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000125	0.000834	CcSEcCtD
Dapagliflozin—Dermatitis—Lacosamide—epilepsy syndrome	0.000125	0.000834	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000125	0.00083	CcSEcCtD
Dapagliflozin—Headache—Lacosamide—epilepsy syndrome	0.000125	0.000829	CcSEcCtD
Dapagliflozin—Constipation—Vigabatrin—epilepsy syndrome	0.000124	0.000827	CcSEcCtD
Dapagliflozin—Urticaria—Midazolam—epilepsy syndrome	0.000124	0.000827	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000124	0.000824	CcSEcCtD
Dapagliflozin—Oedema—Carbamazepine—epilepsy syndrome	0.000124	0.000824	CcSEcCtD
Dapagliflozin—Infestation—Gabapentin—epilepsy syndrome	0.000124	0.000823	CcSEcCtD
Dapagliflozin—Infestation NOS—Gabapentin—epilepsy syndrome	0.000124	0.000823	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000124	0.000822	CcSEcCtD
Dapagliflozin—Discomfort—Lamotrigine—epilepsy syndrome	0.000123	0.000821	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000123	0.00082	CcSEcCtD
Dapagliflozin—Infection—Carbamazepine—epilepsy syndrome	0.000123	0.000819	CcSEcCtD
Dapagliflozin—Constipation—Diazepam—epilepsy syndrome	0.000122	0.000814	CcSEcCtD
Dapagliflozin—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000122	0.000812	CcSEcCtD
Dapagliflozin—Hypotension—Clonazepam—epilepsy syndrome	0.000122	0.000812	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Gabapentin—epilepsy syndrome	0.000122	0.000811	CcSEcCtD
Dapagliflozin—Rash—Clobazam—epilepsy syndrome	0.000122	0.00081	CcSEcCtD
Dapagliflozin—Dermatitis—Clobazam—epilepsy syndrome	0.000122	0.000809	CcSEcCtD
Dapagliflozin—Renal failure—Gabapentin—epilepsy syndrome	0.000122	0.000809	CcSEcCtD
Dapagliflozin—Hypotension—Phenytoin—epilepsy syndrome	0.000121	0.000807	CcSEcCtD
Dapagliflozin—Myocardial infarction—Gabapentin—epilepsy syndrome	0.000121	0.000806	CcSEcCtD
Dapagliflozin—Headache—Clobazam—epilepsy syndrome	0.000121	0.000805	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000121	0.000803	CcSEcCtD
Dapagliflozin—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000121	0.000802	CcSEcCtD
Dapagliflozin—Skin disorder—Carbamazepine—epilepsy syndrome	0.00012	0.0008	CcSEcCtD
Dapagliflozin—Urinary tract infection—Gabapentin—epilepsy syndrome	0.00012	0.0008	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.00012	0.000797	CcSEcCtD
Dapagliflozin—Oedema—Lamotrigine—epilepsy syndrome	0.00012	0.000796	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.00012	0.000795	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.000119	0.000791	CcSEcCtD
Dapagliflozin—Infection—Lamotrigine—epilepsy syndrome	0.000119	0.000791	CcSEcCtD
Dapagliflozin—Urethral disorder—Pregabalin—epilepsy syndrome	0.000119	0.000789	CcSEcCtD
Dapagliflozin—Urticaria—Fosphenytoin—epilepsy syndrome	0.000118	0.000788	CcSEcCtD
Dapagliflozin—Constipation—Felbamate—epilepsy syndrome	0.000118	0.000788	CcSEcCtD
Dapagliflozin—Nausea—Lacosamide—epilepsy syndrome	0.000118	0.000786	CcSEcCtD
Dapagliflozin—ABCB1—midbrain—epilepsy syndrome	0.000118	0.00395	CbGeAlD
Dapagliflozin—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000118	0.000784	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000117	0.000779	CcSEcCtD
Dapagliflozin—Malnutrition—Valproic Acid—epilepsy syndrome	0.000117	0.000775	CcSEcCtD
Dapagliflozin—Constipation—Zonisamide—epilepsy syndrome	0.000116	0.000771	CcSEcCtD
Dapagliflozin—Hypotension—Carbamazepine—epilepsy syndrome	0.000116	0.00077	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000116	0.00077	CcSEcCtD
Dapagliflozin—Urticaria—Vigabatrin—epilepsy syndrome	0.000115	0.000768	CcSEcCtD
Dapagliflozin—ABCB1—spinal cord—epilepsy syndrome	0.000115	0.00385	CbGeAlD
Dapagliflozin—Hypersensitivity—Midazolam—epilepsy syndrome	0.000115	0.000767	CcSEcCtD
Dapagliflozin—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000115	0.000764	CcSEcCtD
Dapagliflozin—Nausea—Clobazam—epilepsy syndrome	0.000115	0.000763	CcSEcCtD
Dapagliflozin—Dizziness—Acetazolamide—epilepsy syndrome	0.000114	0.000757	CcSEcCtD
Dapagliflozin—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000114	0.000757	CcSEcCtD
Dapagliflozin—Urticaria—Diazepam—epilepsy syndrome	0.000114	0.000756	CcSEcCtD
Dapagliflozin—Angina pectoris—Topiramate—epilepsy syndrome	0.000114	0.000756	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000113	0.00075	CcSEcCtD
Dapagliflozin—Back pain—Valproic Acid—epilepsy syndrome	0.000113	0.00075	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000112	0.000745	CcSEcCtD
Dapagliflozin—Constipation—Clonazepam—epilepsy syndrome	0.000112	0.000743	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000111	0.000741	CcSEcCtD
Dapagliflozin—Constipation—Phenytoin—epilepsy syndrome	0.000111	0.000738	CcSEcCtD
Dapagliflozin—Constipation—Oxcarbazepine—epilepsy syndrome	0.00011	0.000734	CcSEcCtD
Dapagliflozin—Urticaria—Felbamate—epilepsy syndrome	0.00011	0.000732	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.00011	0.000729	CcSEcCtD
Dapagliflozin—Body temperature increased—Felbamate—epilepsy syndrome	0.000109	0.000728	CcSEcCtD
Dapagliflozin—Dysuria—Topiramate—epilepsy syndrome	0.000109	0.000726	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000109	0.000726	CcSEcCtD
Dapagliflozin—Urethral disorder—Gabapentin—epilepsy syndrome	0.000109	0.000724	CcSEcCtD
Dapagliflozin—Headache—Acetazolamide—epilepsy syndrome	0.000108	0.000717	CcSEcCtD
Dapagliflozin—Pollakiuria—Topiramate—epilepsy syndrome	0.000108	0.000717	CcSEcCtD
Dapagliflozin—Urticaria—Zonisamide—epilepsy syndrome	0.000108	0.000716	CcSEcCtD
Dapagliflozin—Body temperature increased—Zonisamide—epilepsy syndrome	0.000107	0.000713	CcSEcCtD
Dapagliflozin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000107	0.000712	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000107	0.000711	CcSEcCtD
Dapagliflozin—Angioedema—Valproic Acid—epilepsy syndrome	0.000107	0.000709	CcSEcCtD
Dapagliflozin—Constipation—Carbamazepine—epilepsy syndrome	0.000106	0.000705	CcSEcCtD
Dapagliflozin—Dizziness—Propofol—epilepsy syndrome	0.000106	0.000703	CcSEcCtD
Dapagliflozin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000105	0.000701	CcSEcCtD
Dapagliflozin—Malnutrition—Pregabalin—epilepsy syndrome	0.000105	0.000701	CcSEcCtD
Dapagliflozin—Infestation—Topiramate—epilepsy syndrome	0.000104	0.000692	CcSEcCtD
Dapagliflozin—Infestation NOS—Topiramate—epilepsy syndrome	0.000104	0.000692	CcSEcCtD
Dapagliflozin—Urticaria—Clonazepam—epilepsy syndrome	0.000104	0.00069	CcSEcCtD
Dapagliflozin—Dizziness—Midazolam—epilepsy syndrome	0.000103	0.000688	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000103	0.000688	CcSEcCtD
Dapagliflozin—Body temperature increased—Clonazepam—epilepsy syndrome	0.000103	0.000687	CcSEcCtD
Dapagliflozin—CYP2D6—brain—epilepsy syndrome	0.000103	0.00345	CbGeAlD
Dapagliflozin—Urticaria—Phenytoin—epilepsy syndrome	0.000103	0.000686	CcSEcCtD
Dapagliflozin—Body temperature increased—Phenytoin—epilepsy syndrome	0.000103	0.000682	CcSEcCtD
Dapagliflozin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000103	0.000682	CcSEcCtD
Dapagliflozin—ABCB1—head—epilepsy syndrome	0.000102	0.00342	CbGeAlD
Dapagliflozin—Constipation—Lamotrigine—epilepsy syndrome	0.000102	0.000681	CcSEcCtD
Dapagliflozin—Renal failure—Topiramate—epilepsy syndrome	0.000102	0.00068	CcSEcCtD
Dapagliflozin—Nausea—Acetazolamide—epilepsy syndrome	0.000102	0.00068	CcSEcCtD
Dapagliflozin—Dizziness—Levetiracetam—epilepsy syndrome	0.000102	0.00068	CcSEcCtD
Dapagliflozin—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000102	0.000679	CcSEcCtD
Dapagliflozin—Back pain—Pregabalin—epilepsy syndrome	0.000102	0.000678	CcSEcCtD
Dapagliflozin—Urinary tract infection—Topiramate—epilepsy syndrome	0.000101	0.000673	CcSEcCtD
Dapagliflozin—Rash—Propofol—epilepsy syndrome	0.000101	0.000671	CcSEcCtD
Dapagliflozin—Dermatitis—Propofol—epilepsy syndrome	0.000101	0.00067	CcSEcCtD
Dapagliflozin—Hypertension—Valproic Acid—epilepsy syndrome	0.000101	0.000669	CcSEcCtD
Dapagliflozin—Headache—Propofol—epilepsy syndrome	0.0001	0.000666	CcSEcCtD
Dapagliflozin—Hypersensitivity—Zonisamide—epilepsy syndrome	9.99e-05	0.000664	CcSEcCtD
Dapagliflozin—Rash—Midazolam—epilepsy syndrome	9.86e-05	0.000656	CcSEcCtD
Dapagliflozin—Dizziness—Fosphenytoin—epilepsy syndrome	9.86e-05	0.000656	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	9.86e-05	0.000656	CcSEcCtD
Dapagliflozin—Dermatitis—Midazolam—epilepsy syndrome	9.86e-05	0.000656	CcSEcCtD
Dapagliflozin—Urticaria—Carbamazepine—epilepsy syndrome	9.84e-05	0.000655	CcSEcCtD
Dapagliflozin—Discomfort—Valproic Acid—epilepsy syndrome	9.8e-05	0.000652	CcSEcCtD
Dapagliflozin—Headache—Midazolam—epilepsy syndrome	9.8e-05	0.000652	CcSEcCtD
Dapagliflozin—Body temperature increased—Carbamazepine—epilepsy syndrome	9.79e-05	0.000651	CcSEcCtD
Dapagliflozin—Rash—Levetiracetam—epilepsy syndrome	9.74e-05	0.000648	CcSEcCtD
Dapagliflozin—Dermatitis—Levetiracetam—epilepsy syndrome	9.73e-05	0.000647	CcSEcCtD
Dapagliflozin—ABCB1—nervous system—epilepsy syndrome	9.72e-05	0.00324	CbGeAlD
Dapagliflozin—Headache—Levetiracetam—epilepsy syndrome	9.68e-05	0.000644	CcSEcCtD
Dapagliflozin—Malnutrition—Gabapentin—epilepsy syndrome	9.66e-05	0.000643	CcSEcCtD
Dapagliflozin—Angioedema—Pregabalin—epilepsy syndrome	9.63e-05	0.000641	CcSEcCtD
Dapagliflozin—Hypersensitivity—Clonazepam—epilepsy syndrome	9.63e-05	0.00064	CcSEcCtD
Dapagliflozin—Dizziness—Vigabatrin—epilepsy syndrome	9.61e-05	0.000639	CcSEcCtD
Dapagliflozin—Hypersensitivity—Phenytoin—epilepsy syndrome	9.56e-05	0.000636	CcSEcCtD
Dapagliflozin—Oedema—Valproic Acid—epilepsy syndrome	9.51e-05	0.000633	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	9.51e-05	0.000633	CcSEcCtD
Dapagliflozin—Urticaria—Lamotrigine—epilepsy syndrome	9.51e-05	0.000633	CcSEcCtD
Dapagliflozin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.51e-05	0.000633	CcSEcCtD
Dapagliflozin—Nausea—Propofol—epilepsy syndrome	9.5e-05	0.000632	CcSEcCtD
Dapagliflozin—Body temperature increased—Lamotrigine—epilepsy syndrome	9.46e-05	0.00063	CcSEcCtD
Dapagliflozin—Dizziness—Diazepam—epilepsy syndrome	9.46e-05	0.000629	CcSEcCtD
Dapagliflozin—Infection—Valproic Acid—epilepsy syndrome	9.45e-05	0.000629	CcSEcCtD
Dapagliflozin—Rash—Fosphenytoin—epilepsy syndrome	9.4e-05	0.000625	CcSEcCtD
Dapagliflozin—Dermatitis—Fosphenytoin—epilepsy syndrome	9.39e-05	0.000625	CcSEcCtD
Dapagliflozin—ABCB1—central nervous system—epilepsy syndrome	9.36e-05	0.00312	CbGeAlD
Dapagliflozin—Back pain—Gabapentin—epilepsy syndrome	9.35e-05	0.000622	CcSEcCtD
Dapagliflozin—Headache—Fosphenytoin—epilepsy syndrome	9.34e-05	0.000621	CcSEcCtD
Dapagliflozin—Nausea—Midazolam—epilepsy syndrome	9.29e-05	0.000618	CcSEcCtD
Dapagliflozin—Skin disorder—Valproic Acid—epilepsy syndrome	9.24e-05	0.000615	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Topiramate—epilepsy syndrome	9.22e-05	0.000614	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.2e-05	0.000612	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Topiramate—epilepsy syndrome	9.18e-05	0.000611	CcSEcCtD
Dapagliflozin—Nausea—Levetiracetam—epilepsy syndrome	9.18e-05	0.00061	CcSEcCtD
Dapagliflozin—Rash—Vigabatrin—epilepsy syndrome	9.16e-05	0.00061	CcSEcCtD
Dapagliflozin—Dizziness—Felbamate—epilepsy syndrome	9.16e-05	0.000609	CcSEcCtD
Dapagliflozin—Dermatitis—Vigabatrin—epilepsy syndrome	9.16e-05	0.000609	CcSEcCtD
Dapagliflozin—Urethral disorder—Topiramate—epilepsy syndrome	9.15e-05	0.000609	CcSEcCtD
Dapagliflozin—ABCB1—cerebellum—epilepsy syndrome	9.14e-05	0.00305	CbGeAlD
Dapagliflozin—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.13e-05	0.000607	CcSEcCtD
Dapagliflozin—Headache—Vigabatrin—epilepsy syndrome	9.11e-05	0.000606	CcSEcCtD
Dapagliflozin—Hypertension—Pregabalin—epilepsy syndrome	9.1e-05	0.000605	CcSEcCtD
Dapagliflozin—Rash—Diazepam—epilepsy syndrome	9.02e-05	0.0006	CcSEcCtD
Dapagliflozin—Dermatitis—Diazepam—epilepsy syndrome	9.01e-05	0.0006	CcSEcCtD
Dapagliflozin—Dizziness—Zonisamide—epilepsy syndrome	8.96e-05	0.000596	CcSEcCtD
Dapagliflozin—Headache—Diazepam—epilepsy syndrome	8.96e-05	0.000596	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.91e-05	0.000593	CcSEcCtD
Dapagliflozin—Hypotension—Valproic Acid—epilepsy syndrome	8.89e-05	0.000591	CcSEcCtD
Dapagliflozin—Discomfort—Pregabalin—epilepsy syndrome	8.86e-05	0.00059	CcSEcCtD
Dapagliflozin—Nausea—Fosphenytoin—epilepsy syndrome	8.86e-05	0.000589	CcSEcCtD
Dapagliflozin—Angioedema—Gabapentin—epilepsy syndrome	8.83e-05	0.000587	CcSEcCtD
Dapagliflozin—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.82e-05	0.000587	CcSEcCtD
Dapagliflozin—Rash—Felbamate—epilepsy syndrome	8.73e-05	0.000581	CcSEcCtD
Dapagliflozin—Dermatitis—Felbamate—epilepsy syndrome	8.72e-05	0.00058	CcSEcCtD
Dapagliflozin—Headache—Felbamate—epilepsy syndrome	8.68e-05	0.000577	CcSEcCtD
Dapagliflozin—Dizziness—Clonazepam—epilepsy syndrome	8.64e-05	0.000575	CcSEcCtD
Dapagliflozin—Nausea—Vigabatrin—epilepsy syndrome	8.63e-05	0.000574	CcSEcCtD
Dapagliflozin—Oedema—Pregabalin—epilepsy syndrome	8.6e-05	0.000572	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.6e-05	0.000572	CcSEcCtD
Dapagliflozin—Dizziness—Phenytoin—epilepsy syndrome	8.58e-05	0.000571	CcSEcCtD
Dapagliflozin—Rash—Zonisamide—epilepsy syndrome	8.55e-05	0.000569	CcSEcCtD
Dapagliflozin—Infection—Pregabalin—epilepsy syndrome	8.54e-05	0.000568	CcSEcCtD
Dapagliflozin—Dermatitis—Zonisamide—epilepsy syndrome	8.54e-05	0.000568	CcSEcCtD
Dapagliflozin—Dizziness—Oxcarbazepine—epilepsy syndrome	8.54e-05	0.000568	CcSEcCtD
Dapagliflozin—Nausea—Diazepam—epilepsy syndrome	8.5e-05	0.000565	CcSEcCtD
Dapagliflozin—Headache—Zonisamide—epilepsy syndrome	8.49e-05	0.000565	CcSEcCtD
Dapagliflozin—Skin disorder—Pregabalin—epilepsy syndrome	8.35e-05	0.000556	CcSEcCtD
Dapagliflozin—Hypertension—Gabapentin—epilepsy syndrome	8.34e-05	0.000555	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.31e-05	0.000553	CcSEcCtD
Dapagliflozin—Rash—Clonazepam—epilepsy syndrome	8.24e-05	0.000548	CcSEcCtD
Dapagliflozin—Dermatitis—Clonazepam—epilepsy syndrome	8.23e-05	0.000547	CcSEcCtD
Dapagliflozin—Nausea—Felbamate—epilepsy syndrome	8.23e-05	0.000547	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.21e-05	0.000546	CcSEcCtD
Dapagliflozin—Dizziness—Carbamazepine—epilepsy syndrome	8.19e-05	0.000545	CcSEcCtD
Dapagliflozin—Headache—Clonazepam—epilepsy syndrome	8.18e-05	0.000544	CcSEcCtD
Dapagliflozin—Rash—Phenytoin—epilepsy syndrome	8.18e-05	0.000544	CcSEcCtD
Dapagliflozin—Dermatitis—Phenytoin—epilepsy syndrome	8.17e-05	0.000544	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.17e-05	0.000544	CcSEcCtD
Dapagliflozin—Rash—Oxcarbazepine—epilepsy syndrome	8.14e-05	0.000541	CcSEcCtD
Dapagliflozin—Constipation—Valproic Acid—epilepsy syndrome	8.14e-05	0.000541	CcSEcCtD
Dapagliflozin—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.13e-05	0.000541	CcSEcCtD
Dapagliflozin—Headache—Phenytoin—epilepsy syndrome	8.13e-05	0.000541	CcSEcCtD
Dapagliflozin—Malnutrition—Topiramate—epilepsy syndrome	8.13e-05	0.000541	CcSEcCtD
Dapagliflozin—Discomfort—Gabapentin—epilepsy syndrome	8.13e-05	0.000541	CcSEcCtD
Dapagliflozin—Headache—Oxcarbazepine—epilepsy syndrome	8.09e-05	0.000538	CcSEcCtD
Dapagliflozin—Nausea—Zonisamide—epilepsy syndrome	8.05e-05	0.000536	CcSEcCtD
Dapagliflozin—Hypotension—Pregabalin—epilepsy syndrome	8.04e-05	0.000535	CcSEcCtD
Dapagliflozin—Dizziness—Lamotrigine—epilepsy syndrome	7.92e-05	0.000527	CcSEcCtD
Dapagliflozin—Oedema—Gabapentin—epilepsy syndrome	7.89e-05	0.000525	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.89e-05	0.000525	CcSEcCtD
Dapagliflozin—Back pain—Topiramate—epilepsy syndrome	7.86e-05	0.000523	CcSEcCtD
Dapagliflozin—Infection—Gabapentin—epilepsy syndrome	7.83e-05	0.000521	CcSEcCtD
Dapagliflozin—Rash—Carbamazepine—epilepsy syndrome	7.81e-05	0.00052	CcSEcCtD
Dapagliflozin—Dermatitis—Carbamazepine—epilepsy syndrome	7.8e-05	0.000519	CcSEcCtD
Dapagliflozin—Nausea—Clonazepam—epilepsy syndrome	7.76e-05	0.000516	CcSEcCtD
Dapagliflozin—Headache—Carbamazepine—epilepsy syndrome	7.76e-05	0.000516	CcSEcCtD
Dapagliflozin—Nausea—Phenytoin—epilepsy syndrome	7.71e-05	0.000513	CcSEcCtD
Dapagliflozin—Nausea—Oxcarbazepine—epilepsy syndrome	7.67e-05	0.00051	CcSEcCtD
Dapagliflozin—Skin disorder—Gabapentin—epilepsy syndrome	7.66e-05	0.00051	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.62e-05	0.000507	CcSEcCtD
Dapagliflozin—Urticaria—Valproic Acid—epilepsy syndrome	7.56e-05	0.000503	CcSEcCtD
Dapagliflozin—Rash—Lamotrigine—epilepsy syndrome	7.55e-05	0.000502	CcSEcCtD
Dapagliflozin—Dermatitis—Lamotrigine—epilepsy syndrome	7.54e-05	0.000502	CcSEcCtD
Dapagliflozin—Body temperature increased—Valproic Acid—epilepsy syndrome	7.52e-05	0.0005	CcSEcCtD
Dapagliflozin—Headache—Lamotrigine—epilepsy syndrome	7.5e-05	0.000499	CcSEcCtD
Dapagliflozin—ABCB1—brain—epilepsy syndrome	7.43e-05	0.00248	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.43e-05	0.000494	CcSEcCtD
Dapagliflozin—Hypotension—Gabapentin—epilepsy syndrome	7.37e-05	0.00049	CcSEcCtD
Dapagliflozin—Nausea—Carbamazepine—epilepsy syndrome	7.36e-05	0.000489	CcSEcCtD
Dapagliflozin—Constipation—Pregabalin—epilepsy syndrome	7.35e-05	0.000489	CcSEcCtD
Dapagliflozin—Nausea—Lamotrigine—epilepsy syndrome	7.11e-05	0.000473	CcSEcCtD
Dapagliflozin—Hypertension—Topiramate—epilepsy syndrome	7.02e-05	0.000467	CcSEcCtD
Dapagliflozin—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.01e-05	0.000466	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.87e-05	0.000457	CcSEcCtD
Dapagliflozin—Discomfort—Topiramate—epilepsy syndrome	6.84e-05	0.000455	CcSEcCtD
Dapagliflozin—Urticaria—Pregabalin—epilepsy syndrome	6.83e-05	0.000455	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.81e-05	0.000453	CcSEcCtD
Dapagliflozin—Body temperature increased—Pregabalin—epilepsy syndrome	6.8e-05	0.000452	CcSEcCtD
Dapagliflozin—Constipation—Gabapentin—epilepsy syndrome	6.74e-05	0.000449	CcSEcCtD
Dapagliflozin—Oedema—Topiramate—epilepsy syndrome	6.63e-05	0.000441	CcSEcCtD
Dapagliflozin—Infection—Topiramate—epilepsy syndrome	6.59e-05	0.000439	CcSEcCtD
Dapagliflozin—Skin disorder—Topiramate—epilepsy syndrome	6.44e-05	0.000429	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Topiramate—epilepsy syndrome	6.41e-05	0.000427	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pregabalin—epilepsy syndrome	6.34e-05	0.000422	CcSEcCtD
Dapagliflozin—Dizziness—Valproic Acid—epilepsy syndrome	6.29e-05	0.000419	CcSEcCtD
Dapagliflozin—Urticaria—Gabapentin—epilepsy syndrome	6.27e-05	0.000417	CcSEcCtD
Dapagliflozin—Body temperature increased—Gabapentin—epilepsy syndrome	6.23e-05	0.000415	CcSEcCtD
Dapagliflozin—Hypotension—Topiramate—epilepsy syndrome	6.2e-05	0.000412	CcSEcCtD
Dapagliflozin—Rash—Valproic Acid—epilepsy syndrome	6e-05	0.000399	CcSEcCtD
Dapagliflozin—Dermatitis—Valproic Acid—epilepsy syndrome	5.99e-05	0.000399	CcSEcCtD
Dapagliflozin—Headache—Valproic Acid—epilepsy syndrome	5.96e-05	0.000396	CcSEcCtD
Dapagliflozin—Hypersensitivity—Gabapentin—epilepsy syndrome	5.81e-05	0.000387	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.73e-05	0.000381	CcSEcCtD
Dapagliflozin—Dizziness—Pregabalin—epilepsy syndrome	5.69e-05	0.000378	CcSEcCtD
Dapagliflozin—Constipation—Topiramate—epilepsy syndrome	5.67e-05	0.000377	CcSEcCtD
Dapagliflozin—Nausea—Valproic Acid—epilepsy syndrome	5.65e-05	0.000376	CcSEcCtD
Dapagliflozin—Rash—Pregabalin—epilepsy syndrome	5.42e-05	0.000361	CcSEcCtD
Dapagliflozin—Dermatitis—Pregabalin—epilepsy syndrome	5.42e-05	0.00036	CcSEcCtD
Dapagliflozin—Headache—Pregabalin—epilepsy syndrome	5.39e-05	0.000358	CcSEcCtD
Dapagliflozin—Urticaria—Topiramate—epilepsy syndrome	5.27e-05	0.000351	CcSEcCtD
Dapagliflozin—Body temperature increased—Topiramate—epilepsy syndrome	5.25e-05	0.000349	CcSEcCtD
Dapagliflozin—Dizziness—Gabapentin—epilepsy syndrome	5.22e-05	0.000347	CcSEcCtD
Dapagliflozin—Nausea—Pregabalin—epilepsy syndrome	5.11e-05	0.00034	CcSEcCtD
Dapagliflozin—Rash—Gabapentin—epilepsy syndrome	4.97e-05	0.000331	CcSEcCtD
Dapagliflozin—Dermatitis—Gabapentin—epilepsy syndrome	4.97e-05	0.00033	CcSEcCtD
Dapagliflozin—Headache—Gabapentin—epilepsy syndrome	4.94e-05	0.000329	CcSEcCtD
Dapagliflozin—Hypersensitivity—Topiramate—epilepsy syndrome	4.89e-05	0.000325	CcSEcCtD
Dapagliflozin—Nausea—Gabapentin—epilepsy syndrome	4.68e-05	0.000312	CcSEcCtD
Dapagliflozin—Dizziness—Topiramate—epilepsy syndrome	4.39e-05	0.000292	CcSEcCtD
Dapagliflozin—Rash—Topiramate—epilepsy syndrome	4.18e-05	0.000278	CcSEcCtD
Dapagliflozin—Dermatitis—Topiramate—epilepsy syndrome	4.18e-05	0.000278	CcSEcCtD
Dapagliflozin—Headache—Topiramate—epilepsy syndrome	4.16e-05	0.000277	CcSEcCtD
Dapagliflozin—Nausea—Topiramate—epilepsy syndrome	3.94e-05	0.000262	CcSEcCtD
Dapagliflozin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	5.39e-06	4.94e-05	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—AKT1—epilepsy syndrome	5.36e-06	4.91e-05	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—AKT1—epilepsy syndrome	5.36e-06	4.91e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GPX1—epilepsy syndrome	5.33e-06	4.89e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADSL—epilepsy syndrome	5.32e-06	4.87e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.3e-06	4.86e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.3e-06	4.86e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.29e-06	4.84e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	5.26e-06	4.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	5.26e-06	4.82e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	5.23e-06	4.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	5.23e-06	4.79e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GLUL—epilepsy syndrome	5.22e-06	4.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	5.21e-06	4.77e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	5.21e-06	4.77e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.18e-06	4.75e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.18e-06	4.75e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	5.12e-06	4.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	5.12e-06	4.69e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.09e-06	4.66e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.09e-06	4.66e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.07e-06	4.65e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	5.03e-06	4.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADSL—epilepsy syndrome	5.01e-06	4.59e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.99e-06	4.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.97e-06	4.55e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.96e-06	4.54e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.91e-06	4.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.9e-06	4.49e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	4.9e-06	4.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.87e-06	4.46e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	4.86e-06	4.45e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.82e-06	4.42e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.8e-06	4.4e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CAT—epilepsy syndrome	4.79e-06	4.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	4.79e-06	4.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.79e-06	4.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.78e-06	4.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—BCHE—epilepsy syndrome	4.77e-06	4.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	4.76e-06	4.36e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.76e-06	4.36e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.73e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.73e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.73e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.73e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.73e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.72e-06	4.32e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AGT—epilepsy syndrome	4.68e-06	4.28e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	4.66e-06	4.27e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.65e-06	4.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	4.64e-06	4.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	4.64e-06	4.25e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—APOE—epilepsy syndrome	4.58e-06	4.2e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	4.55e-06	4.17e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.51e-06	4.13e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	4.5e-06	4.12e-05	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AKT1—epilepsy syndrome	4.49e-06	4.11e-05	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AKT1—epilepsy syndrome	4.49e-06	4.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TH—epilepsy syndrome	4.49e-06	4.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.47e-06	4.1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.43e-06	4.06e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.43e-06	4.06e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.38e-06	4.01e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.34e-06	3.98e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GPX1—epilepsy syndrome	4.33e-06	3.97e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.33e-06	3.97e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.32e-06	3.96e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.32e-06	3.96e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.32e-06	3.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	4.29e-06	3.93e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.25e-06	3.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.25e-06	3.89e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.2e-06	3.85e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.2e-06	3.85e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	4.18e-06	3.83e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.17e-06	3.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.16e-06	3.81e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.16e-06	3.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	4.16e-06	3.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.13e-06	3.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.09e-06	3.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.02e-06	3.68e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.02e-06	3.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.96e-06	3.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.96e-06	3.63e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—POMC—epilepsy syndrome	3.94e-06	3.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.93e-06	3.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.93e-06	3.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.82e-06	3.5e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AGT—epilepsy syndrome	3.8e-06	3.48e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.78e-06	3.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.76e-06	3.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	3.75e-06	3.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	3.74e-06	3.43e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—APOE—epilepsy syndrome	3.72e-06	3.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.71e-06	3.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CAT—epilepsy syndrome	3.69e-06	3.38e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.68e-06	3.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.66e-06	3.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	3.59e-06	3.29e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ALB—epilepsy syndrome	3.59e-06	3.29e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.58e-06	3.28e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.58e-06	3.28e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.58e-06	3.28e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	3.57e-06	3.27e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.56e-06	3.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—BCHE—epilepsy syndrome	3.56e-06	3.26e-05	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AKT1—epilepsy syndrome	3.47e-06	3.17e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.43e-06	3.14e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.42e-06	3.13e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.42e-06	3.13e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	3.39e-06	3.11e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.36e-06	3.07e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.36e-06	3.07e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	3.35e-06	3.07e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.34e-06	3.06e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TH—epilepsy syndrome	3.34e-06	3.06e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GPX1—epilepsy syndrome	3.34e-06	3.06e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.34e-06	3.06e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.32e-06	3.04e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.29e-06	3.01e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.28e-06	3e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.23e-06	2.96e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.21e-06	2.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.2e-06	2.93e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—POMC—epilepsy syndrome	3.2e-06	2.93e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.16e-06	2.9e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.15e-06	2.89e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.15e-06	2.88e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	3.14e-06	2.88e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.13e-06	2.87e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.13e-06	2.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.12e-06	2.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.1e-06	2.84e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.08e-06	2.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.06e-06	2.81e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3e-06	2.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.95e-06	2.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AGT—epilepsy syndrome	2.93e-06	2.68e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—epilepsy syndrome	2.92e-06	2.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOE—epilepsy syndrome	2.87e-06	2.63e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.86e-06	2.62e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.86e-06	2.62e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.85e-06	2.61e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.84e-06	2.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.81e-06	2.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.8e-06	2.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	2.79e-06	2.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAT—epilepsy syndrome	2.75e-06	2.52e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.74e-06	2.51e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.71e-06	2.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.69e-06	2.46e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.68e-06	2.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	2.68e-06	2.45e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.68e-06	2.45e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TH—epilepsy syndrome	2.67e-06	2.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.67e-06	2.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.66e-06	2.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.65e-06	2.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.65e-06	2.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.63e-06	2.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.59e-06	2.37e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.59e-06	2.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.55e-06	2.34e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	2.55e-06	2.34e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.53e-06	2.32e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.53e-06	2.31e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TH—epilepsy syndrome	2.52e-06	2.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.5e-06	2.29e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TH—epilepsy syndrome	2.49e-06	2.28e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX1—epilepsy syndrome	2.49e-06	2.28e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—POMC—epilepsy syndrome	2.47e-06	2.26e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.46e-06	2.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.4e-06	2.2e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.39e-06	2.19e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.28e-06	2.09e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.27e-06	2.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—epilepsy syndrome	2.25e-06	2.06e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.23e-06	2.04e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAT—epilepsy syndrome	2.2e-06	2.01e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AGT—epilepsy syndrome	2.18e-06	2e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.16e-06	1.98e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.14e-06	1.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOE—epilepsy syndrome	2.14e-06	1.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TH—epilepsy syndrome	2.13e-06	1.95e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.11e-06	1.93e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	1.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.1e-06	1.92e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.07e-06	1.9e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.06e-06	1.88e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.04e-06	1.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.02e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2e-06	1.83e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.99e-06	1.82e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	1.8e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.87e-06	1.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.86e-06	1.7e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.85e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.84e-06	1.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.78e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.76e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.76e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.75e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.74e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.71e-06	1.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.71e-06	1.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.68e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.67e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.65e-06	1.51e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.65e-06	1.51e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.64e-06	1.51e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.63e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.61e-06	1.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.6e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.59e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	1.58e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.47e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.47e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.39e-06	1.27e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.38e-06	1.27e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.37e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.37e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.36e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.35e-06	1.24e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.34e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.32e-06	1.21e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKT1—epilepsy syndrome	1.28e-06	1.17e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.26e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.25e-06	1.14e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.23e-06	1.12e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.17e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.17e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	1.01e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	1e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.07e-06	9.84e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.07e-06	9.78e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.05e-06	9.64e-06	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKT1—epilepsy syndrome	9.89e-07	9.06e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.34e-07	8.56e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—POMC—epilepsy syndrome	9.04e-07	8.28e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.24e-07	7.55e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKT1—epilepsy syndrome	7.37e-07	6.75e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.21e-07	6.61e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.88e-07	5.39e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.54e-07	5.08e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.5e-07	5.03e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.7e-07	4.3e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.62e-07	3.32e-06	CbGpPWpGaD
